Differential heparanase-1 expression in malignant and benign pheochromocytomas

Journal of Surgical Research

Volumn 108, Issue 1, 2002, Pages 44-50

  Quiros, Roderick M ^a   Kim, Anthony W ^a   Maxhimer, Justin ^a   Gattuso, Paolo ^a   Xu, Xiulong ^a   Prinz, Richard A ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; HEPARANASE; PARAFFIN;

ADRENAL CORTEX ADENOMA; ADULT; AGED; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER METASTASIS; MALE; MEDICAL RECORD; NEPHRECTOMY; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RNA PROBE; STATISTICAL ANALYSIS;

EID: 0036436752     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.2002.6451     Document Type: Article

References (24)

1. Bravo, E. Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. Endocr. Rev. 15: 356, 1994.
2. Scott, H. W., and Halter, S. Oncologic aspects of pheochromocytoma: The importance of follow-up. Surgery 96: 1061, 1984.
3. Medeiros, L. J., Wolf, B., Balogh, K., and Federman, M. Adrenal pheochromocytoma: A clinicopathologic review of 60 cases. Hum. Pathol. 16: 580, 1985.
4. Moley, J., and Wells, S. Pituitary and adrenal glands. In C. Townsend et al. (Eds.), Sabiston Textbook of Surgery, the Biological Basis of Modern Surgical Practice, 16th Ed. Philadelphia: Saunders, 2001. Pp. 662-695.
5. Toyoshima, M., and Nakajima, M. Human heparanase: Purification, characterization, cloning, and expression. J. Biol. Chem. 274: 24153, 1999.
6. Hulett, M. D., Freeman, C., Hamdorf, B., Baker, R., Harris, M., and Parish, C. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nature Med. 5: 803, 1999.
7. Freeman, C., and Parish, C. Human platelet heparanase: Purification, characterization, and catalytic activity. Biochem. J. 330: 1341, 1998.
8. Kussie, P., Hulmes, J., Ludwig, D., Patel, S., Navarro, C., Seddon, A., Giorgio, N., and Bohlen, P. Cloning and functional expression of a human heparanase gene. Biochem. Biophys. Res. Commun. 261: 183, 1999.
9. Eccles, S. Heparanase: Breaking down barriers in tumors. Nature Med. 5: 735, 1999.
10. Vlodavsky, I., Friedmann, Y., Elkin, M., Aingorn, H., Atzmon, R., Ishai-Michaeli, R., Bitan, M., Pappo, O., Peretz, T., Michal, I., Spector, L., and Pecker, I. Mammalian heparanase: Gene cloning, expression, and function in tumor progression and metastasis. Nature Med. 5: 793, 1999.
11. Walch, E., Albino, A., and Marchetti, D. Correlation of overexpression of the low-affinity p75 neurotrophin receptor with augmented invasion and heparanase production in human malignant melanoma cells. Int. J. Cancer 82: 112, 1999.
12. Koliopanos, A., Friess, H., Kleeff, J., Shi, X., Liao, Q., Pecker, I., Vlodavsky, I., Zimmerman, A., and Buchler, M. Heparanase expression in primary and metastatic pancreatic cancer. Cancer Res. 61: 4655, 2001.
13. Friedmann, Y., Vlodavsky, I., Aingorn, H., Aviv, A., Peretz, T., Pecker, I., and Pappo, O. Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma: Evidence for its role in colonic tumorigenesis. Am. J. Pathol. 157: 1167, 2000.
14. John, H., Ziegler, W., Hauri, D., and Jaeger, P. Pheochromocytomas: Can malignant potential be predicted? Urology 53: 679, 1999.
15. Rao, F., Keiser, H., and O'Connor, D. Malignant pheochromocytoma: Chromaffin granule transmitter and response to treatment. Hypertension 1045, 2000.
16. Heaney, A., O'Rourke, D., Arthur, K., Beatty, O., Russell, C., Sloan, J., Hamilton, P., and Atkinson, A. Flow cytometric analysis does not reliably differentiate benign from malignant phaeochromocytoma. Clin. Endocrinol. 44: 233, 1996.
17. Helman, L., Cohen, P., AVerbuch, S., Cooper, M., Keiser, H., and Israel, M. Neuropeptide Y expression distinguishes malignant from benign pheochromocytoma. J. Clin. Oncol. 7: 1720, 1989.
18. Krijger, R., Van Der Harst, E., Van Der Ham, F., Stijnen, T., Dinjens, W., Koper, J., Bruining, H., Lamberts, S., and Bosman, F. Prognostic value of p53, bcl-2, and c-erb B2 protein expression in phaeochromocytomas. J. Pathol. 188: 51, 1999.
19. Komminoth, P., Kunz, K., Hiort, O., Schroder, S., Matias-Guiu, X., Christiansen, G., Roth, J., and Heitz, P. Detection of RET proto-oncogene point mutations in paraffin-embedded pheochromocytoma specimens by nonradioactive single-strand conformation polymorphism analysis and direct sequencing. Am. J. Pathol. 145: 922, 1994.
20. Van Der Harst, E., Bruining, H., Bonjer, H., Van Der Ham, F., Dinjens, W., Lamberts, S., De Herder, W., Koper, J., Stinjen, T., Proye, C., Lecomte-Houke, M., Bosman, F., and De Krijger, R. Proliferative index in pheochromocytomas: Does it predict the occurrence of metastases? J. Pathol. 191: 175, 2000.
21. Brown, H., Komorowski, R., Wilson, S., Demeure, M., and Zhu, Y. Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation: A positive correlation between MIB-1 staining and malignant tumor behavior. Cancer 86: 1583, 1999.
22. Kubota, Y., Nakada, T., Sasagawa, I., Yanai, H., and Itoh, K. Elevated levels of telomerase activity in malignant pheochromocytoma. Cancer 82: 176, 1998.
23. Elkin, M., Ilan, N., Ishai-Michaeli, R., Friedmann, Y., Papo, O., Pecker, I., and Vlodavsky, I. Heparanase as mediator of angiogenesis: Mode of action. FASEB J. 15: 1661, 2001.
24. Liu, Q., Djuricin, G., Staren, E., Gattuso, P., Gould, V., Shen, J., Saclarides, T., Rubin, D., and Prinz, R. Tumor angiogenesis in pheochromocytomas and paragangliomas. Surgery 120: 938, 1996.